Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03291587 · ClinicalTrials.gov registry record · NA
Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,094
- Enrollment target
NCT03291587: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03291587 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,094 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03291587, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,094 participants
- Enrollment target
Study Summary
Evaluate a multi-faceted training program to improve short-term smoking cessation rates (\<14 days post-visit) and short (3 months) and sustained abstinence (6 months) among 1,114 enrolled smokers who present for low-dose computed tomography (LDCT) lung cancer screening in 26 community-based practices.
Primary Outcome
7-day sustained smoking abstinence will be measured by the question "Have you smoked a cigarette (or other tobacco products), even a puff, in the last 7 days?" in patient survey.
Interventions
- OTHER Personnel Training and Coaching Calls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,094 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-02-22 |
| Phase | NA |
What the finished NCT03291587 record still lists
NCT03291587 is an interventional study that assigns participants to a tested intervention. Its 1,094 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 1 intervention - of which Personnel Training and Coaching Calls is the first listed.
NCT03291587 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03291587 about?
NCT03291587 is a clinical study titled "Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites". Evaluate a multi-faceted training program to improve short-term smoking cessation rates (\<14 days post-visit) and short (3 months) and sustained abstinence (6 months) among 1,114 enrolled smokers who present for low-dose computed tomography (LDCT) lung cancer screening in 26 community-based practic...
What is the current status of trial NCT03291587?
This trial is currently completed. It is a NA study. The enrollment target is 1,094 participants. The study started on 2018-06-01. Estimated completion is 2021-02-22.
What interventions are being tested in trial NCT03291587?
The interventions under investigation include: Personnel Training and Coaching Calls (OTHER).
Who is sponsoring clinical trial NCT03291587?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03291587's enrollment target sits among peer trials
1,094 95th of 2000 higher than 1,906 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03754114 · 1,094 participants · NA
Brain Oxygen Optimization in Severe TBI, Phase 3
- NCT06118983 · 1,094 participants · NA
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
- NCT06585241 · 1,094 participants · Phase 4
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- NCT06191744 · 1,095 participants · Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI